Autologous T cells control B-chronic lymphocytic leukemia tumor progression in human→mouse radiation chimera

被引:0
|
作者
Shimoni, A
Marcus, H
Dekel, B
Shkarchi, R
Arditti, F
Shvidel, L
Shtalrid, M
Bucher, W
Canaan, A
Ergas, D
Berrebi, A
Reisner, Y [1 ]
机构
[1] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel
[2] Kaplan Hosp, Inst Hematol, IL-76100 Rehovot, Israel
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B-chronic lymphocytic leukemia (B-CLL) is characterized by the clonal accumulation of CD5(+) B cells, It has been suggested that CLL cells may be regulated by inhibitory and growth-promoting signals exerted by autologous T cells. We have recently described a model for human B-CLL in which peripheral blood mononuclear cells (PBMCs) are transplanted into the peritoneal cavity of lethally irradiated mice radioprotected with bone marrow from mice with severe combined immunodeficiency, In this model, adoptive transfer of low-stage PBMCs leads to marked engraftment of T cells or combined T and CLL cell engraftment, whereas infusion of high-stage PBMCs leads to dominance of CLL cells with a miniscule level of T-cell engraftment. This mutual exclusive pattern of engraftment indicated that T. cells might control the expansion of tumor cells in the peritoneum of recipient BALB/c mice. In the present study, we further investigated this question and we demonstrate that is vivo T-cell depletion, using OKT3 antibody, markedly enhances the engraftment of B-CLL cells from patients with early-stage disease. In mice receiving PBMCs from 11 donors with advanced stage disease, the results were more heterogeneous, In five patients the results were similar to those observed in early stage, whereas in two cases no CLL cell engraftment was found in the absence of T cells. The addition of purified T cells to PBMCs led to a substantial decrease of CLL engraftment in three advanced-stage cases. These results strengthen the working hypothesis that autologous T cells can actively suppress the expansion of the pathological cells in human-->mouse radiation chimera. This effect is prominent in early-stage disease, whereas in advanced stage suppresive and/or stimulatory effects may occur in different patients, The interaction of T cells with tumor cells and the potential of autologous T cell/immune-therapy in CLL can be further explored in this model.
引用
收藏
页码:5968 / 5974
页数:7
相关论文
共 50 条
  • [1] Model for human B-chronic lymphocytic leukemia in human/mouse radiation chimera: Evidence for tumor-mediated suppression of antibody production in low-stage disease
    Shimoni, A
    Marcus, H
    Canaan, A
    Ergas, D
    David, M
    Berrebi, A
    Reisner, Y
    BLOOD, 1997, 89 (06) : 2210 - 2218
  • [2] Methylation profile of B-chronic lymphocytic leukemia cells
    Fan, J
    Norio, A
    Matsuoka, M
    BLOOD, 2005, 106 (11) : 828A - 828A
  • [3] FUNCTIONAL DIFFERENCES OF T-CELLS IN B-CHRONIC LYMPHOCYTIC-LEUKEMIA
    ANTICA, M
    KUSIC, B
    SPAVENTI, R
    JAKSIC, B
    VITALE, B
    LEUKEMIA & LYMPHOMA, 1993, 9 (1-2) : 133 - 140
  • [4] Autologous T-cells control B-CLL cell engraftment in a human/mouse radiation chimera.
    Shimoni, A
    Marcus, H
    Arditi, F
    Berrebi, A
    Reisner, Y
    BLOOD, 1997, 90 (10) : 2372 - 2372
  • [5] Activity of vinorelbine on B-chronic lymphocytic leukemia cells in vitro
    Bernabei, PA
    Landini, I
    Bartolozzi, B
    Banchelli, I
    Nocentini, ADIO
    Santini, V
    Ematologia, UO
    DRUG RESISTANCE IN LEUKEMIA AND LYMPHOMA III, 1999, 457 : 473 - 476
  • [6] B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor α
    Rosati, E
    Sabatini, R
    Tabilio, A
    Di Ianni, M
    Bartoli, A
    Marconi, P
    LEUKEMIA RESEARCH, 2005, 29 (07) : 829 - 839
  • [7] Oligoclonal T cell expansions in B-chronic lymphocytic leukemia.
    Paniagua, M
    Abshari, M
    Peterson, L
    Tallman, M
    Goolsby, C
    CYTOMETRY, 2000, 42 (05): : 321 - 321
  • [8] CELL-CYCLE PROGRESSION OF B-CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS INDUCED TO DIFFERENTIATE BY TPA
    CARLSSON, M
    TOTTERMAN, TH
    MATSSON, P
    NILSSON, K
    BLOOD, 1988, 71 (02) : 415 - 421
  • [9] B-chronic lymphocytic leukemia: A malignancy of anti-self B cells
    CaligarisCappio, F
    BLOOD, 1996, 87 (07) : 2615 - 2620
  • [10] Angiogenic status of blood B cells in B-chronic lymphocytic leukemia.
    Kay, NE
    Geyer, SM
    Hillman, DW
    Bone, ND
    Tschumper, RC
    Howell, KH
    Hanson, CA
    Dewald, GW
    Jelinek, DF
    BLOOD, 2001, 98 (11) : 361A - 361A